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Table
Prescription of celecoxib and other NSAIDs for OA: Stratiﬁed by active patient
request
Active
Request
Celecoxib NSAID,
not Cox-2
Celecoxib OR
non-selective
Neither
Yes 51 (53%) 28 (29%) 79 (82%) 17 (18%)
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RACE INTERACTIONS AND FOOT FUNCTION IN OLDER ADULTS: THE
JOHNSTON COUNTY OSTEOARTHRITIS PROJECT
M.T. Hannan y, A.B. Dufour z, Y.M. Golightly x, V.A. Casey z,
T.J. Hagedorn z, J.L. Riskowski y, H.J. Hillstrom k, J.M. Jordan x. yHebrew
SeniorLife & Harvard Med. Sch., Roslindale, MA, USA; zHebrew
SeniorLife, Roslindale, MA, USA; xUniv. of North Carolina, Chapel Hill,
NC, USA; kHosp. for Special Surgery, NY, USA
Purpose: Center of pressure excursion index (CPEI), a measure that
characterizes pronation and supination, may be a useful indicator of
foot function. Data from the predominantly Caucasian Framingham
Foot Study have shown that CPEI differed signiﬁcantly by age and sex.
The purpose of this study was to examine whether demographic and
clinical traits were associated with CPEI in a large bi-racial cohort of
men and women  50 years of age.
Methods: Of the 1695 Johnston County Osteoarthritis Project partici-
pants clinically evaluated in 2006-2010, 1466 were enrolled in
a comprehensive foot study. As part of the exam, participants were
instructed towalk at a self-selected pace over a TekscanMatscan system
(Tekscan, Inc., Boston) using the two-step method. Two plantar pres-
sure scans were recorded for each foot. Custom software was used to
calculate CPEI and was averaged for each foot; the foot with the aver-
aged CPEI value farthest from themedianwas used in analyses. A higher
CPEI value indicates a more supinated foot, while lower CPEI indicates
a more pronated foot. Characteristics included sex, age (< 65 or  65
years), body mass index (BMI, <30 or  30 kg/m2), and race (Caucasian
or African-American). Student's t-test was used to identify those factors
associated with differences in mean CPEI for the sample and stratiﬁed
by sex. Linear regression was used to evaluate interactions of contin-
uous factors (age and BMI) by race.
Results: Participants (67% women, 29% African-American) had mean
age of 68 years and mean BMI of 31 kg/m2. The mean CPEI was
smaller among women than men (p<0.0001, Table). In the total
sample, CPEI differed by age group with participants 65+ yrs having
lower CPEI (p<0.0001), indicating a tendency toward more pronation
with age. When this difference was stratiﬁed by sex (Table), women
65+ yrs continued to have lower CPEI (p¼0.0002); men had a similar
result albeit with borderline statistical signiﬁcance (p¼0.07). CPEI did
not differ by BMI or by race. However, signiﬁcant interactions were
noted between race and continuous age (p¼0.022), as well as
between race and continuous BMI (p¼0.026), with CPEI in women
only. While older women of either race had lower CPEI (as did those
with higher BMI), the difference was twice as large in African-
American (w3.2 CPEI units, p¼0.002) than Caucasian women (w1.5
units, p¼0.02).
Conclusions: Similar to results reported in the Caucasian Framingham
Foot Study, we found signiﬁcant differences in mean CPEI that indicate
over-pronation for those aged 65+ yrs and for women, but found no
link between CPEI and BMI. While there was no main effect by race for
the categorical data, the interactions in women by race imply that
there may be a greater age effect towards pronation in older African-
American women. This might indicate more foot pathology, an
underlying genetic component of foot function or perhaps even more
need for treatment of the pronated foot in this group.Table
T-tests for associations between demographic and clinical variables and CPEI in men and women
Males N Mean CPEI Standard Deviation p Females N Mean CPEI Standard Deviation p
Sex 481 16.3 8.4 Sex 985 14.4 8.8 <.0001
Age < 65 214 17.1 8.8 0.07 Age < 65 384 15.7 8.5 0.0002
Age  65 267 15.7 7.9 Age  65 601 13.6 8.9
BMI < 30 241 16.4 8.6 0.78 BMI < 30 477 14.0 9.1 0.13
BMI  30 240 16.2 8.1 BMI  30 508 14.8 8.4
Caucasian 363 16.6 8.2 0.13 Caucasian 671 14.4 8.7 0.72
African-Am 118 15.3 8.8 African-Am 314 14.6 9.1
No 23 (24%) 40 (42%) 63 (66%) 33 (34%)286
THE ACTIVATED PATIENT INFLUENCES PRIMARY CARE PHYSICIANS'
PRESCRIPTIONS OF CELEBREX FOR OSTEOARTHRITIS
J.N. Katz y, L.D. Marceau z, F.L. Trachtenberg z, M.A. Fischer y, J. Yu z,
J.B. McKinlay z, J.B. McKinlay z. yBrigham and Women's Hosp., Boston,
MA, USA; zNew England Res. Inst., Watertown, MA, USAPurpose: Direct to consumer marketing of medications is intended to
“activate” patients to request the advertised medication from their
physicians. There is limited data on the extent to which physicians alter
prescribing patterns in response to speciﬁc requests from activated
patients.
Methods: We performed a factorial experiment in which primary care
physicians viewed clinically authentic videotapes of “patients” presenting
with symptomatic knee osteoarthritis (OA). The “patients” were played
by professional actors who differed by sex, race (white, Black, Hispanic)
and SES (higher, lower).192 primary care physicians working primarily in
Illinois were recruited to participate. Each physician viewed one
vignette of a patient with typical symptoms of knee OA lasting for
several months. In one half of vignettes the patient was ‘activated’ and
asked: “I've seen ads for Celebrex and it looks just like what I need/A
woman I work with takes it and she said it really works for her/so, I really
want to try that.” The non activated patients requested help with their
pain but did not ask for any speciﬁc medications: “I just want something
to make it better.” Activated and nonactivated vignettes were balanced
on sex, race and SES. Physicians were balanced by sex and years of
experience. After viewing the videotape, the physicians completed
a questionnaire in which they indicated the treatment(s) they would
likely order. We examined the association between patient character-
istics, particularly activated vs. non-activated, and the medications the
physicians said they would prescribe (celecoxib, non-selective NSAIDs,
other) using a multivariate ANOVA model.
Results: 53% of the PCPs presented with a vignette including an active
request for celecoxib reported that they would prescribe celecoxib, as
compared with 24% of physicians seeing the identical vignette without
an active medication request (p<0.0001; Table). Physicians receiving an
active request for celecoxib were less likely to report that they would
prescribe a non-selective NSAID (29%) than physicians whose simulated
patients did not request celecoxib (42%; p¼0.06). Further, physicians
who received an active request for celecoxib prescribed either a COX-2
OR a traditional NSAID for 82% of vignettes, compared to 66% of
physicians who did not receive an active request (p¼0.004). The asso-
ciations between active request and physician prescribing patterns
were not inﬂuenced by patient characteristics (gender, race, SES) or
physician characteristics (gender, experience).
Conclusions: Physicians presented with an activated request for cele-
coxib by a patient with typical knee OA were more than twice as likely
to prescribe celecoxib compared to physicians encountering a non-
activated patient who provided the same clinical history and they were
also considerably more likely to prescribe any NSAID (selective or non-
selective) . Given the higher price, increased risk of cardiovascular
toxicity and similar efﬁcacy of celecoxib compared to non-selective
NSAIDs, these ﬁndings suggest that patient activation may increase
health care costs and compromise appropriateness of prescribing.287
VITAMIN K STATUS AND MRI-BASED KNEE OSTEOARTHRITIS
CHARACTERISTICS IN COMMUNITY-DWELLING OLDER ADULTS: THE
HEALTH ABC STUDY
M. Shea y, S.B. Kritchevsky y, F.-C. Hsu y, M.C. Nevitt z, C. Kwoh x,
S.L. Booth k, C. Vermeer {, R.F. Loeser y. yWake Forest Sch. of Med.,
Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S153Winston Salem, NC, USA; zUniv. of California San Francisco, San Francisco,
CA, USA; xUniv. of Pittsburgh, Pittsburgh, PA, USA; k Tufts Univ. Human
Nutrition Res. Ctr. on Aging, Boston, MA, USA; {VitaK, Univ. of
Maastricht, Maastricht, The Netherlands
Several vitamin K dependent proteins are present in joint tissues,
including matrix gla protein (MGP) which functions as a calciﬁcation
inhibitor. In order for MGP to function it must be g-carboxylated, which
requires vitamin K. Ex vivo studies suggest MGP carboxylation is rele-
vant to osteoarthritis (OA). Assays that measure uncarboxylated MGP
(ucMGP) in plasma have been developed, and elevated plasma ucMGP
reﬂects lower vitamin K status. Whether or not plasma ucMGP is
associated with OA is unclear.
Purpose: To determine the association between plasma ucMGP and
vitamin K1 and knee OA features assessed using MRI in the Health
Aging and Body Composition (Health ABC) study of well-functioning
community-dwelling older adults.
Methods: 437 participants with qualifying knee pain and 144 randomly
chosen controls underwent bilateral knee MRIs (meanSD age ¼ 743
yr; 66% female). Using the WORMS method, the anterior, central, and
posterior of the medial/lateral femoral condyles/tibial plateaus and
medial/lateral subregions of the patella were each semi-quantitatively
scored separately for cartilage damage, bone marrow lesions, sub-
articular cysts, osteophytes, and bone attrition. Meniscal damage was
scored separately in medial and lateral compartments and synovitis
was assessed in the whole knee. Vitamin K status was measured
according to plasma ucMGP and vitamin K1 concentrations. Using the
knee as the unit of analysis, the ORs (95%CIs) for presence of OA char-
acteristics were calculated using logistic regression with generalized
estimating equations (GEEs, to account for between-knee correlation),
according to quartile of each vitamin K status measure. Linear regres-
sionwith GEEs was used to compare the scores for each knee OA feature
across vitamin K status quartiles. Adjustment was made for age, gender,
race, BMI, smoking status, interleukin-6, and education.
Results: Those with lower plasma ucMGP (reﬂective of better vitamin K
status) were signiﬁcantly less likely to have any bone marrow lesions
[OR(95%CI) comparing lowest to highest quartile: 0.59(0.39-0.91), p-
trend¼0.01] and osteophytes [OR(95%CI)¼0.55(0.37-0.84), p-
trend¼0.004]. There was a borderline trend for a lower prevalence of
meniscal damage [OR(95%CI)¼0.68(0.44-1.04), p-trend¼0.049] and
subarticular cysts [OR(95%CI)¼0.75(0.50-1.14), p-trend¼0.07]. In the
linear models, plasma ucMGP was signiﬁcantly positively associated
with total bone marrow lesion score (beta coefﬁcient¼0.085; p¼0.003)
and total subarticular cyst score (beta coefﬁcient¼0.071; p¼0.003).
Plasma ucMGPwas not associatedwith cartilage damage (p0.16), bone
attrition (p0.53), or synovitis (p0.90) and plasma vitamin K1 was not
associated with any MRI knee OA feature (all p0.22).
Conclusion: In this cross-sectional analysis, a marker of lower
vitamin K status, plasma ucMGP, but not vitamin K1 itself was asso-
ciated with some knee OA MRI features, especially those related to
subchondral bone. Longitudinal analyses are needed to determine
whether either plasma ucMGP or vitamin K1, predict changes in knee
OA features.288
CIGARETTE SMOKING AND RISK OF SEVERE OSTEOARTHRITIS
AMONG CHINESE IN SINGAPORE - THE SINGAPORE CHINESE
HEALTH STUDY
W.-P. Koh y, K. Leung z, L. Ang x, J. Thumboo z. yDuke-NUS Graduate Med.
Sch. Singapore, Singapore, SINGAPORE; z Singapore Gen. Hosp., Singapore,
Singapore; xMinistry of Hlth.Singapore, Singapore, Singapore
Purpose: Although cigarette smoking has been associated with
a protective effect for osteoarthritis (OA) in several Western studies,
results are conﬂicting and none has examined the effect of smoking
cessation. There is alsonodata fromAsiancountrieswhere theprevalence
of knee OA is increasing. We aimed to examine smoking status, duration,
dosage and cessation in relation to the risk of total knee replacement
(TKR) for severe knee OA among elderly Chinese in Singapore.
Methods: We used data from the Singapore Chinese Health Study,
a population-based prospective cohort of 63,257 Chinese men and
women aged 45 to 74 years at enrolment between 1993 and 1998.
Detailed information on smoking, current diet, medical history and
lifestyle factors were obtained through in-person interviews at enroll-
ment. The cohort has been continuously followed, both actively throughre-interviews and passively through computer linkage to population-
based death and cancer registries. Loss to follow-up has been negligible.
As of 31 December 2011, after a mean follow-up of 14.5 years, 1,950
incident TKR cases for severe knee OA (324 cases inmen and 1,626 cases
in women) were identiﬁed via linkage with nationwide hospital
discharge database. We used the Cox regression models to examine
smoking in relation to risk of TKR with adjustment for age at and year of
study enrollment, level of education, body mass index and physical
activity level.
Results: Compared to never smokers, current smokers had a statisti-
cally signiﬁcant 51% decrease in risk of TKR [hazards ratio (HR)¼0.49;
95% conﬁdence interval (CI)¼0.40-0.60], while former smokers had
a 15% reduction in risk (HR¼0.85; 95% CI¼0.69-1.04). The risk estimates
were similar between both genders. Among current smokers, there was
a very strong dose-dependent association between increasing duration
of smoking and decreasing risk of TKR. Compared to never smokers, the
relative risk decreased from 0.81 (95% CI¼0.47-1.39) in the current
smokers who had smoked less than 20 years to 0.36 (95% CI¼0.26-0.50)
in those who had smoked for 40 or more years (p for trend<0.0001). A
strong negative linear effect of smoking intensity was also detected
with the relative risk decreasing from 0.55 (95% CI¼0.43-0.71) in
current smokers who smoked fewer than 13 cigarettes per day to 0.33
(95% CI¼0.14-0.80) in those who smoked at least 33 cigarettes per day
(p for trend<0.0001), when compared to never smokers. Among former
smokers, there was a stepwise dose-dependent attenuation in the risk
reduction of TKR with duration of cessation. Compared to never
smokers, the relative risk of TKR was 0.68 among those who had quit
less than 1 year, and increased to 0.98 in those who had quit for at least
20 years (p for trend<0.0001).
Conclusions: Our ﬁndings strongly implicate cigarette smoking as
a protective factor for severe osteoarthritis, and this protection is rapidly
lost with smoking cessation. This concurs with experimental data that
nicotine promotes proliferation and collagen synthesis in chondrocytes.
While we certainly do not advocate smoking as a means of preventing
onset or progression of osteoarthritis, understanding the role of nicotine
will elucidate pathogenesis of OA and help in the development of che-
mopreventive agents targeting this putative pathway.289
SYMPTOMATIC HAND OSTEOARTHRITIS (OA) AND THE
ASSOCIATIONS TO MORTALITY AND CARDIOVASCULAR EVENTS -
DATA FROM THE FRAMINGHAM OA STUDY
I.K. Haugen y, V. Ramachandran z, D. Misra z, T. Neogi z, J. Niu z,
T. Yang x, Y. Zhang z, D.T. Felson z. yDiakonhjemmet Hosp., Oslo, Norway;
zBoston Univ. Med. Ctr., Boston, MA, USA; xBoston Univ. Med. Ctr.,
Boston, MI, USA
Purpose: To study whether participants with symptomatic hand OA
had increased mortality and more cardiovascular events in a pop-
ulation-based cohort, and to explore mechanisms behind a potential
association.
Methods: We included participants from the Framingham Original
and Offspring cohorts between 50 and 75 years, without rheumatoid
arthritis and with available hand radiographs and/or information
about hand pain enabling classiﬁcation of symptomatic hand OA.
Symptomatic hand OA was deﬁned as one or more hand joint(s) with
radiographic OA (Kellgren Lawrence grade 2 or more) and pain in the
same joint(s). Overall mortality included mortality related to
cardiovascular events, cancer and mortality due to unknown/
unspeciﬁed causes. For cardiovascular events, we focused on incident
coronary heart disease (coronary insufﬁciency/myocardial infarc-
tion), congestive heart failure and/or atherothrombotic brain infarc-
tion. The diagnoses were arrived at by a panel of cardiologists/
neurologists using published criteria after review of clinical exami-
nations and hospitalization records. As covariates we included body
mass index (BMI), blood glucose, lipid proﬁle, blood pressure,
medication use (lipid-lowering, antihypertensive, antidiabetics,
nonsteroidal anti-inﬂammatory drugs and aspirin), smoking and
alcohol (for mortality: also previous cardiovascular events and
cancer). The associations to cardiovascular events were studied in
those with no previous events. We examined whether symptomatic
hand OA was associated with all-cause mortality and cardiovascular
events using Cox proportional hazards models adjusting for age, sex,
cohort and BMI (adjusted model one), as well as other covariates at
baseline (adjusted model two).
